Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Hologic, Inc. (HOLX)

79.2   0.67 (0.85%) 03-24 16:00
Open: 78.5 Pre. Close: 78.53
High: 79.3 Low: 78.07
Volume: 1,140,566 Market Cap: 19,527(M)

Technical analysis

as of: 2023-03-24 4:26:46 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 93.99     One year: 96.89
Support: Support1: 76.44    Support2: 63.6
Resistance: Resistance1: 80.47    Resistance2: 82.95
Pivot: 78.64
Moving Average: MA(5): 78.88     MA(20): 78.95
MA(100): 77.96     MA(250): 73.63
MACD: MACD(12,26): -0.6     Signal(9): -0.7
Stochastic oscillator: %K(14,3): 52     %D(3): 54.3
RSI: RSI(14): 48.7
52-week: High: 86.65  Low: 59.77
Average Vol(K): 3-Month: 1,606 (K)  10-Days: 1,363 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ HOLX ] has closed below upper band by 32.0%. Bollinger Bands are 53.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 79.34 - 79.73 79.73 - 80.13
Low: 77.14 - 77.55 77.55 - 77.97
Close: 78.54 - 79.19 79.19 - 79.85

Company Description

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Headline News

Fri, 24 Mar 2023
Catalent (CTLT) Inks Deal for Nasal Spray for Opioid Overdoses - Nasdaq

Fri, 24 Mar 2023
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a ... - Nasdaq

Fri, 24 Mar 2023
Flagship Harbor Advisors LLC Takes $443000 Position in Hologic ... - MarketBeat

Thu, 23 Mar 2023
First Hawaiian Bank Raises Stock Position in Hologic, Inc. (NASDAQ ... - MarketBeat

Tue, 21 Mar 2023 featured highlights include AutoNation, Atkore, Valero ... - Nasdaq

Mon, 13 Mar 2023
Hologic, Inc. (NASDAQ:HOLX) Receives Consensus ... - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 247 (M)
Shares Float 245 (M)
% Held by Insiders 0.7 (%)
% Held by Institutions 99.7 (%)
Shares Short 6,560 (K)
Shares Short P.Month 7,260 (K)

Stock Financials

EPS 3.8
EPS Est Next Qtl 0.51
EPS Est This Year 2
EPS Est Next Year 2.15
Book Value (p.s.) 20.65
Profit Margin (%) 22.1
Operating Margin (%) 28.5
Return on Assets (ttm) 8.5
Return on Equity (ttm) 20.6
Qtrly Rev. Growth -27
Gross Profit (p.s.) 13.42
Sales Per Share 18.13
EBITDA (p.s.) 6.81
Qtrly Earnings Growth -61.5
Operating Cash Flow 1,810 (M)
Levered Free Cash Flow 1,550 (M)

Stock Valuations

PE Ratio 20.78
PEG Ratio 2
Price to Book value 3.83
Price to Sales 4.36
Price to Cash Flow 10.78

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.